Exudаtive pericarditis: eight years of clinical experience. Part I: data from clinical trials and statistical studies

  • V. V. Telepov National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • S. V. Salo National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • E. M. Trembovetskaya National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • E. V. Rudenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • V. L. Ganul National Cancer Institute of Ministry of Health of Ukraine (Kiev)
  • B. O. Borisyuk National Cancer Institute of Ministry of Health of Ukraine (Kiev)
  • D. B. Starosyla L. V. Gromashevsky National Institute of Epidemiology and Infectious Diseases NAMS (Kiev)
  • M. A. Sokoliuk Kiev Regional Oncologic Dispensary
Keywords: exudative pericarditis, two-stage intra-pericardial chemotherapy, isolation and identification of viruses, dot-ELISA, sclerosing of the pericardium, research methods, cis-platinum, proteflazidum

Abstract

The aim of this review is to analyze and to discuss the methods of exudative pericarditis (EP) research including also new ones, being important for the understanding of this problem on the territory of Ukraine. For this purpose, we have chosen the most “popular” EP types; they were investigated in our country during 29 years, i.e. during 21 years before the introduction of new technologies and 8 years following this event; we describe here comparative qualitative and quantitative characteristics of different EP types.

References

1. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association Cardio-Thoracic Surgery (EACTS) // Eur Heart J. – 2015. – Vol. 36 (42). – P. 2921–64.

2. Imazio M., Adler Y. Management of pericardial effusion // Eur. Heart J. – 2013. – Vol. 34. – P. 2232–2237.

3. Imazio M., Mayosi B.M., Brucato A. et al. Triage and management of pericardial effusion // J. Cardiovasc. Med. (Hagerstown). – 2011. – Vol. 11. – P. 928–935.

4. Imazio M., Contemporary management off pericardial diseases // Curr. Opin. Cardiol. – 2012. – Vol. 27. – P. 308–317.

5. Выделение и идентификация вирусов при экссудативном перикардите / Телепов В. В., Федорченко Д. Б., Иванская Н. В., Сало С. В., Рыбалко С. Л., Попов В. В. // Бюл. НЦССХ имени А. Н. Бакулева РАМН. Сердечно-сосудистые заболевания. – 2009. – Т. 10, № 3.

6. Значение прицельно-локальной внутриперикардиальной химиотерапии при экссудативных перикардитах / Телепов В. В., Книшов Г. В., Попов В. В., Сало С. В., Борисюк Б. О. // Щорічник «Серцево-судинна хірургія». – К., 2009. – № 17.

7. Применение двухэтапной внутриперикардиальной химиотерапии при онкологических заболеваниях органов переднего средостения, сопровождающихся экссудативным перикардитом / Телепов В. В., Попов В. В., Сало С. В., Трембовецкая Е. М., Руденко Е. В. // Щорічник «Серцево-судинна хірургія». – К., 2010. – № 18. – С. 594–597.
Published
2016-09-12
How to Cite
1.
Telepov VV, Salo SV, Trembovetskaya EM, Rudenko EV, Ganul VL, Borisyuk BO, Starosyla DB, Sokoliuk MA. Exudаtive pericarditis: eight years of clinical experience. Part I: data from clinical trials and statistical studies. ujcvs [Internet]. 2016Sep.12 [cited 2024Dec.22];(2 (25):97-100. Available from: http://cvs.org.ua/index.php/ujcvs/article/view/246
Section
OTHER DISEASES OF THE CARDIOVASCULAR SYSTEM